Physician profile
Milton Glatterer
NPI 1013962372
$1,944.06
in general payments reported to CMS, 2019-2025
10 companies · $62.75 in 2025
The $62.75 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $268 · 2021: $75.87 · 2022: $382 · 2023: $150 · 2024: $122 · 2025: $62.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $786.98 | 2019 | |
| Atricure, INC. | $307.95 | 2021-2025 | Atriclip Laa Exclusion System |
| Terumo Cardiovascular Systems Corporation | $229.57 | 2019-2022 | |
| Edwards Lifesciences Corporation | $169.89 | 2019-2020 | |
| Abiomed | $136.86 | 2024-2025 | Impella |
| Bard Peripheral Vascular, INC. | $111.02 | 2020 | |
| Getinge USA Sales, LLC | $99.22 | 2023 | Vasoview Hemopro 2 |
| Corcym INC | $50.94 | 2023 | Perceval |
| Jazz Pharmaceuticals INC. | $26.19 | 2025 | |
| Boston Scientific Corporation | $25.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milton Glatterer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.